We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.98B
AUM Growth
+$213M
Cap. Flow
+$184M
Cap. Flow %
6.16%
Top 10 Hldgs %
56.07%
Holding
51
New
12
Increased
15
Reduced
12
Closed
11

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$141M
2
JNJ icon
Johnson & Johnson
JNJ
+$90.5M
3
AGN
Allergan plc
AGN
+$84.8M
4
THC icon
Tenet Healthcare
THC
+$76.8M
5
INCY icon
Incyte
INCY
+$75.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$188M
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$136M
3
EW icon
Edwards Lifesciences
EW
+$98.6M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.3M
5
CAH icon
Cardinal Health
CAH
+$84.5M

Sector Composition

Rank Sector Weight
1 Healthcare 78.08%
2 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
51
CALL
DELISTED
Express Scripts Holding Company
ESRX
– –
-500,000
Closed -$31.9M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2017 Portfolio in Review

As of Q3 2017, HealthCor Management held 51 positions worth $2.98B, up 7.7% from $2.77B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HealthCor Management deployed $184M of net new capital in Q3 2017, opening 12 new positions and adding to 15 existing holdings. Its largest new stake was Johnson & Johnson: 683,050 shares worth $88.8M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $188M trimmed.

  • HealthCor Management's largest Q3 2017 buy was Johnson & Johnson: 683,050 shares worth $88.8M.
  • HealthCor Management added most to Zimmer Biomet in Q3 2017, an estimated $141M increase.
  • HealthCor Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $188M.
  • HealthCor Management fully exited Cardinal Health in Q3 2017, selling an estimated $84.5M.
  • HealthCor Management's ten largest holdings make up 56% of its $2.98B portfolio in Q3 2017.
  • HealthCor Management opened 12 new positions and closed 11 in Q3 2017.
  • HealthCor Management's portfolio value rose 7.7% quarter-over-quarter to $2.98B.

Based on HealthCor Management's 13F filing for Q3 2017, filed 14 Nov 2017.